NRX Pharmaceuticals Inc (NRXP)

5.82 +0.32  +5.82% NASDAQ Dec 6, 13:44 USD
View Full Chart
Price Chart
View All NRXP News

News

View All Events

Events

Date Type Description
02/28/2022 Earnings Results Q4 2021 Earnings Results
02/28/2022 Earnings Calls Q4 2021 Earnings Call
11/16/2021 Earnings Results Q3 2021 Earnings Results
11/16/2021 08:30 EST Earnings Calls Q3 2021 Earnings Call
08/17/2021 08:30 EST Earnings Calls Q2 2021 Earnings Call
08/16/2021 Earnings Results Q2 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
  • URL: https://nrxpharma.com
  • Investor Relations URL: https://ir.nrxpharma.com/
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Feb. 28, 2022
  • Last Earnings Release: Nov. 16, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.